Literature DB >> 6769714

Control of prolactin secretion in mammals.

J A Clemens, C J Shaar.   

Abstract

Evidence describing the neuroendocrine regulation of prolactin secretion in mammals is reviewed, with focus on catecholamines, serotonin, and polypeptides. Dopamine may be a physiological prolactin inhibiting factor (PIF), while norepinephrine and possibly epinephrine regulate prolactin release at the level of the hypothalamus. Serotonin may participate in the regulation of prolactin secretion by stimulating the release of prolactin releasing factor (PRF). The identity of PRF is not known, but two polypeptides--thyrotropin releasing hormone and vasoactive intestinal polypeptide--can act directly on the adenohypophysis to stimulate prolactin release.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6769714

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  6 in total

1.  Subnormal prolactin responsiveness to thyrotropin-releasing hormone (TRH) in women with primary empty sella syndrome.

Authors:  M F Celani; G Giambuzzi; M Simoni; V Montanini
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

2.  Endocrine and neurochemical effects of (+)-PHNO, a dopamine D2 agonist.

Authors:  C M Gust; S K Hemrick-Luecke; R W Fuller
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

Review 3.  Neurotransmitters couple brain activity to subventricular zone neurogenesis.

Authors:  Stephanie Z Young; M Morgan Taylor; Angélique Bordey
Journal:  Eur J Neurosci       Date:  2011-03       Impact factor: 3.386

4.  Prolactin response following intravenous and oral sulpiride in healthy human subjects in relation to sulpiride concentrations.

Authors:  F A Wiesel; G Alfredsson; M Ehrnebo; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

5.  Effects of pergolide on diethylstilbestrol-induced rat pituitary hyperplasia.

Authors:  R V Lloyd; K Schmidt; V Nath
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

6.  The effect of short-term metformin treatment on plasma prolactin levels in bromocriptine-treated patients with hyperprolactinaemia and impaired glucose tolerance: a pilot study.

Authors:  Robert Krysiak; Joanna Okrzesik; Boguslaw Okopien
Journal:  Endocrine       Date:  2014-09-20       Impact factor: 3.633

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.